MILBORNE PORT SURGERY
GAINSBOROUGH, MILBOURNE PORT, SHERBORNECHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CHD 9 | 2005 | 182 | 198 | 91.9% | |
CHD 9 | 2006 | 182 | 200 | 91.0% | |
CHD 9 | 2007 | 175 | 176 | 99.4% | |
CHD 9 | 2008 | 180 | 200 | 90.0% | |
CHD 9 | 2009 | 184 | 202 | 91.1% | |
CHD 9 | 2010 | 174 | 193 | 90.2% | |
CHD 9 | 2011 | 180 | 196 | 91.8% | |
CHD 9 | 2012 | 188 | 202 | 93.1% | |
CHD 9 | 2013 | 191 | 206 | 92.7% | |
CHD005 | 2014 | 193 | 212 | 91.0% | |
CHD005 | 2015 | 199 | 225 | 88.4% | |
CHD005 | 2016 | 204 | 230 | 88.7% | |
CHD005 | 2017 | 203 | 229 | 88.6% | |
CHD005 | 2018 | 246 | 269 | 91.4% | |
CHD005 | 2019 | 263 | 295 | 89.2% | |
CHD005 | 2020 | 273 | 284 | 96.1% | |
CHD005 | 2021 | 265 | 288 | 92.0% | |
CHD005 | 2022 | 265 | 289 | 91.7% | |
CHD005 | 2023 | 284 | 292 | 97.3% |